Immage Biotherapeutics Corp.
IMMG · OTC
2/28/2017 | 11/30/2016 | 8/31/2016 | 5/31/2016 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $54 | $197 | $197 | $265 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $8 | $8 | $0 |
| Total Curr. Assets | $57 | $205 | $205 | $265 |
| Property Plant & Equip (Net) | $28 | $32 | $32 | $34 |
| Goodwill | $0 | $0 | $0 | $5 |
| Intangibles | $6 | $6 | $6 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $34 | $38 | $38 | $40 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $91 | $243 | $243 | $305 |
| Liabilities | – | – | – | – |
| Payables | $48 | $3 | $0 | $0 |
| Short-Term Debt | $0 | $53 | $53 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $111 | $0 | $3 | $56 |
| Total Curr. Liab. | $68 | $56 | $56 | $56 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $68 | $56 | $56 | $56 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $152 | $147 | $147 | $0 |
| Retained Earnings | -$2,018 | -$303 | -$303 | -$241 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $1,888 | $343 | $343 | $490 |
| Total Equity | $22 | $187 | $187 | $249 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $91 | $243 | $243 | $305 |
| Net Debt | -$54 | -$144 | -$144 | -$265 |